Fosfonet

Fosfonet

SCHEMBL413303

O=C(O)CP(=O)(O)O.c1ccc(CCc2ccccc2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.58
MEN1 O00255 1/20 0.58
LMNA P02545 1/20 0.58
HPGD P15428 1/20 0.58
BLM P54132 1/20 0.58
KMT2A Q03164 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
FFAR1 O14842 1/20 0.55
KEAP1 Q14145 1/20 0.54
ANPEP P15144 3/20 0.52
ERAP1 Q9NZ08 2/20 0.52
ERAP2 Q6P179 1/20 0.52
HDAC1 Q13547 3/20 0.50
HDAC3 O15379 2/20 0.50
HDAC4 P56524 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC10 Q969S8 2/20 0.50
HDAC11 Q96DB2 2/20 0.50
HDAC8 Q9BY41 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
5-Phenylvaleric Acid SCHEMBL8767462 0.86 MAPT (0.71) TSHRLMNAFFAR1KEAP1HDAC1
Biphenyl SCHEMBL28009043 0.83 LMNA (0.64) TSHRMEN1LMNAHPGDBLM
Phosphoric Acid SCHEMBL412030 0.82 TSHR (0.61) TSHRTDP1FFAR1KEAP1ANPEP
Fosfonet SCHEMBL28201782 0.81 TDP1 (0.61) TSHRMEN1LMNAHPGDBLM
SCHEMBL1685302 0.80 KEAP1 (0.55) TSHRTDP1FFAR1KEAP1ANPEP
SCHEMBL1314342 0.80 TSHR (0.67) TSHRFFAR1KEAP1ANPEPERAP1
SCHEMBL8371905 0.78 TSHR (0.57) TSHRHPGDTDP1FFAR1KEAP1
Fosfonet SCHEMBL15511066 0.78 TDP1 (0.56) TSHRMEN1LMNAHPGDBLM
SCHEMBL9041685 0.77 HDAC1 (0.58) TSHRTDP1HDAC1HDAC3HDAC4
SCHEMBL11510970 0.77 TSHR (0.62) TSHRKEAP1HDAC1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022024-A1 ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-01-26 US disclosed
WO-2010123599-A9 ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2011-02-17 WO disclosed
WO-2010123599-A2 ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022024-A1 ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS CUTA, MMP8, CLPP TSHR 4335/4885MEN1 4323/4885LMNA 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.